{"filing":{"accession_number":"0001104659-26-088487","cik":"0002072188","ticker":"BIOT","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","form":"6-K","filing_date":"2026-07-30","report_date":"2026-07-29","primary_document":"tm2621671d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2072188/000110465926088487/tm2621671d1_6k.htm"},"events":[{"id":22129,"run_id":19998,"accession_number":"0001104659-26-088487","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"This press release announces Instinct Bio's strategic decision to launch a subscription-model beauty clinic business under its Japanese brand \"GENRÊVER CLINIC\" in Indonesia, with an initial investment of approximately US$1 million across five clinics. The disclosure describes a new business line and market entry strategy positioned as a gateway to the company's regenerative-medicine focus. While this is a material operational and strategic initiative that would affect a reasonable investor's assessment of the company's business direction and capital deployment, it does not fit neatly into the specific event categories (it is neither M\u0026A, a discrete executive change, nor a financial obligation); accordingly, it is classified as an operational/strategic business event under `operational_other`.","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","ticker":"BIOT","filing_date":"2026-07-30","form":"6-K","submitted_at":null,"items":[{"id":21983,"accession_number":"0001104659-26-088487","item_number":"EX-99.1","item_title":"tm2621671d1_ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This press release announces Instinct Bio's strategic decision to launch a subscription-model beauty clinic business under its Japanese brand \"GENRÊVER CLINIC\" in Indonesia, with an initial investment of approximately US$1 million across five clinics. The disclosure describes a new business line and market entry strategy positioned as a gateway to the company's regenerative-medicine focus. While this is a material operational and strategic initiative that would affect a reasonable investor's assessment of the company's business direction and capital deployment, it does not fit neatly into the specific event categories (it is neither M\u0026A, a discrete executive change, nor a financial obligation); accordingly, it is classified as an operational/strategic business event under `operational_other`.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-31T00:01:13.346299+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":21983,"accession_number":"0001104659-26-088487","item_number":"EX-99.1","item_title":"tm2621671d1_ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This press release announces Instinct Bio's strategic decision to launch a subscription-model beauty clinic business under its Japanese brand \"GENRÊVER CLINIC\" in Indonesia, with an initial investment of approximately US$1 million across five clinics. The disclosure describes a new business line and market entry strategy positioned as a gateway to the company's regenerative-medicine focus. While this is a material operational and strategic initiative that would affect a reasonable investor's assessment of the company's business direction and capital deployment, it does not fit neatly into the specific event categories (it is neither M\u0026A, a discrete executive change, nor a financial obligation); accordingly, it is classified as an operational/strategic business event under `operational_other`.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-31T00:01:13.346299+00:00","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","ticker":"BIOT","filing_date":"2026-07-30"}]}